Search the web
Welcome, Guest
[Sign Out, My Account]

Wednesday, October 1 2014 2:32pm ET - U.S. Markets close in 1 hour and 28 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drugs - Generic
Composite Value: 1422.2
Today's Change: -0.06%
S&P 500: -1.17%
chart for
[Drugs - Generic (^YHOh785)]
Drugs - Generic News
Galectin Therapeutics' Abstract Accepted as Oral Presentation at The Liver Meeting(R), Annual Meeting of the American Association for the Study of Liver Diseases
47 minutes ago (GlobeNewswire)
NORCROSS, Ga. -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the Company's abstract titled "Early ...
Stifel Raises Price Target On Salix Pharmaceuticals, Ltd. On Possible Takeover - ()
[$$] Hospira Receives FDA Warning Letter - (at The Wall Street Journal Online)
More News on Drugs - Generic: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
BIOFRONTERA N [B8F.DE] +10.91% $0
Adamas Pharmaceuticals, Inc. [ADMS] +5.16% $312.0 M
SCYNEXIS, Inc. [SCYX] +4.87% $62.8 M
CANNAVEST CORP. [CANV] +3.90% $93.4 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
LUPIN LIMITED [LUPIN.NS] -0.63% $625.9 B
LUPIN LTD. [LUPIN.BO] -0.54% $625.8 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
10/20/14 VRX.TO Valeant Pharmaceuticals International Inc Q3 2014 Earnings Release
10/22/14 MDCO Medicines Co Q3 2014 Earnings Release
10/22/14 ORX.ST Orexo AB Q3 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
09/29/14 AKRX Akorn, Inc. upgraded by RBC Capital Mkts
09/22/14 ACT Actavis plc Ordinary Shares downgraded by Barclays
09/09/14 CTLT Catalent, Inc. Common Stock coverage initiated by William Blair
More Recent Events...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
Clinical Trial Initiation
Accelerate clinical trial start-up, site selection, and recruitment.
Domain Names From $6
$6 domains. Over 45 extensions. Loads of free extras at great prices!
(What's This?)
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:7,484B
Price / Earnings:66.8
Price / Book:-18.9
Net Profit Margin (mrq):6.8%
Price To Free Cash Flow (mrq):-71.9
Return on Equity:24.6%
Total Debt / Equity:48.2
Dividend Yield:0.6%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?